AIM: To evaluate liver tumor motion and how well reference measurement predicts motion during treatment. MATERIAL AND METHODS: This retrospective study included 20 patients with colorectal cancer that had metastasized to the liver who were treated with stereotactic ablative radiotherapy. An online respiratory tumor tracking system was used. Tumor motion amplitudes in the superior-inferior (SI), latero-lateral (LL), and anterior-posterior (AP) directions were collected to generate patient-specific margins. Reference margins were generated as the mean motion and 95th percentile of motion from measurements recorded for different lengths of time (1, 3, and 5 min). We analyzed the predictability of tumor motion in each axis, based on the reference measurement and intra-/interfraction motions. RESULTS: About 96,000 amplitudes were analyzed. The mean tumor motions were 9.9 ± 4.2 mm, 2.6 ± 0.8 mm, and 4.5 ± 1.8 mm in the SI, LL, and AP directions, respectively. The intrafraction variations were 3.5 ± 1.8 mm, 0.63 ± 0.35 mm, and 1.4 ± 0.65 mm for the SI, LL, and AP directions, respectively. The interfraction motion variations were 1.32 ± 0.79 mm, 0.31 ± 0.23 mm, and 0.68 ± 0.62 mm for the SI, LL, and AP directions, respectively. The Pearson's correlation coefficients for margins based on the reference measurement (mean motion or 95th percentile) and margins covering 95% of the motion during the whole treatment were 0.8-0.91, 0.57-0.7, and 0.77-0.82 in the SI, LL, and AP directions, respectively. CONCLUSION: Liver tumor motion in the SI direction can be adequately represented by the mean tumor motion amplitude generated from a single 1 min reference measurement. Longer reference measurements did not improve results for patients who were well-educated about the importance of regular breathing. Although the study was based on tumor tracking data, the results are useful for ITV delineation when tumor tracking is not available.

Dept of Oncology University Hospital Ostrava Ostrava Czech Republic

Dept of Radiology University Hospital Ostrava Ostrava Czech Republic

VŠB Technical University of Ostrava Ostrava Czech Republic

Zobrazit více v PubMed

Lo S.S., Fakiris A.J., Chang E.L. Stereotactic body radiation therapy for oligometastases. Expert Rev Anticancer Ther. 2009;9(5):621–635. PubMed

Bahl A., Kapoor R., Singh P.K. Locally ablative non-surgical management of colo-rectal liver metastasis. J Gastrointest Cancer. 2013;44(1):108–110. PubMed

Harris S.L., Tepper J.E. Radiation to the liver for hepatic metastases from colorectal cancer: stereotactic radiotherapy and radioactive microspheres. Curr Colorectal Cancer Rep. 2009;5(3):140–147.

Dawood O., Mahadevan A., Goodman K.A. Stereotactic body radiation therapy for liver metastases. Eur J Cancer. 2009;45(17):2947–2959. PubMed

Martin A., Gaya A. Stereotactic body radiotherapy: a review. Clin Oncol. 2010;22:157–172. PubMed

Rule W., Timmerman R., Tong L. Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol. 2011;18(4):1081–1087. PubMed

Aitken K.L., Hawkins M.A. Stereotactic body radiotherapy for liver metastases. Clin Oncol. 2015;27:307–315. PubMed

International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy. 1999 Supplement to report 50 Report 62 Washington, DC: ICRU.

Hoogeman M., Prevost J.B., Nuyttens J., Pöll J., Levendag P., Heijmen B. Clinical accuracy of the respiratory tumor tracking system of the cyberknife: assessment by analysis of log files. Int J Radiat Oncol Biol Phys. 2009;74:297–303. PubMed

Case R.B., Moseley D.J., Sonke J.J. Interfraction and intrafraction changes in amplitude of breathing motion in stereotactic liver radiotherapy. Int J Radiat Oncol Biol Phys. 2010;77(3):918–925. PubMed

Keall P. 4-Dimensional computed tomography imaging and treatment planning. Semin Radiat Oncol. 2004;14(1):81–90. PubMed

Xi M., Liu M.Z., Deng X.W. Defining internal target volume (ITV) for hepatocellular carcinoma using four-dimensional CT. Radiother Oncol. 2007;84(3):272–278. PubMed

Xi M., Liu M.Z., Li Q.Q., Cai L., Zhang L., Hu Y.H. Analysis of abdominal organ motion using four-dimensional CT. Chin J Cancer. 2009;28(9):989–993. PubMed

Xi M., Liu M.Z., Zhang L. How many sets of 4D-CT images are sufficient to determine internal target volume for liver radiotherapy? Radiother Oncol. 2009;92(2):255–259. PubMed

Hallman J.L., Mori S., Sharp G.C., Lu H., Hong T.S., Chen G.T.Y. A four-dimensional computed tomography analysis of multiorgan abdominal motion. Int J Radiat Oncol Biol Phys. 2012;83:435–441. PubMed

Goldstein S.D., Ford E.C., Duhon M., McNutt T., Wong J., Herman J.M. Use of respiratory-correlated four-dimensional computed tomography to determine acceptable treatment margins for locally advanced pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2010;76:597–602. PubMed

Brock K.K., Sharpe M.B., Dawson L.A., Kim S.M., Jaffray D.A. Accuracy of finite element model-based multi-organ deformable image registration. Med Phys. 2005;32(6):1647–1659. PubMed

Ge J., Santanam L., Noel C., Parikh P.J. Planning 4-dimensional computed tomography (4D-CT) cannot adequately represent daily intrafractional motion of abdominal tumors. Int J Radiat Oncol Biol Phys. 2013;85:999–1005. PubMed